Assessment of the IgG Trough Level in Subjects With Primary Immunodeficiency Switching From Standard Subcutaneous Immunoglobulin (SCIG) to Every Other Week HyQvia
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2018
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Pharmacokinetics
- 12 Apr 2018 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.
- 12 Apr 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Mar 2019.
- 21 Aug 2017 Status changed from not yet recruiting to recruiting.